by Team Small News | Feb 1, 2026 | Cipla, Pharma
HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla’s Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC’s expertise in creating healthcare facilities that prioritize patient-centric care...
by Team Small News | Jan 26, 2026 | Cipla, Pharma, Sun Pharma, Zydus
Several major pharmaceutical companies, including Sun Pharma, Cipla, Zydus, and Graviti Pharmaceuticals, are recalling various products in the US due to manufacturing issues, according to recent US FDA enforcement reports. The recalls are primarily related to problems... by Team Small News | Jan 21, 2026 | Cipla, Pharma
Cipla, a leading pharmaceutical company, has partnered with ImmunoACT, a biotech firm, to launch CAR-T cell therapy for the treatment of blood cancers in Africa. This collaboration aims to make this innovative and potentially life-saving treatment more accessible to...
by Team Small News | Jan 15, 2026 | Cipla, Lupin, Pharma, Sun Pharma, Zydus
The Indian pharmaceutical industry is bracing for a challenging earnings season in Q3, with expectations of muted margins due to the loss of patent exclusivity for the blockbuster blood cancer drug Revlimid in the US. Revlimid, which has generated over $100 billion in... by Team Small News | Dec 6, 2025 | Cipla, Pharma
Cipla, a leading pharmaceutical company, has partnered with Stempeutics, a stem cell therapy company, to launch a stem cell-based treatment for knee osteoarthritis in India. This innovative therapy aims to provide relief to patients suffering from knee osteoarthritis,... by Team Small News | Dec 1, 2025 | Cipla, Pharma
Cipla, a leading pharmaceutical company, has launched a dedicated lung health diagnostics centre in Delhi, India. This initiative is part of the company’s efforts to reimagine Indian healthcare and provide comprehensive care to patients with respiratory...